Robert Pietrusko

Robert Pietrusko is a declared insider of Viropharma Inc, with filings sourced from SEC (Form 4). We count 35 filings; the first trade dates from 31 August 2011 and the latest from 24 January 2014.

Sales make up the whole of the open-market record (6 sales, €1.8M). Besides market trades, the filings include 11 share grants and 16 option exercises.

On 28 January 2014 came the latest disclosure, a transaction for €2.6M in Viropharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.